Gastric cancer: Epidemiology, pathology and treatment

Annals of Oncology

Volumn 14, Issue SUPPL. 2, 2003, Pages

  Alberts, S R ^a   Cervantes, A ^b   van de Velde, C J H ^c  

^a MAYO CLINIC   (United States)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CISPLATIN; CYTOTOXIC AGENT; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; EPIRUBICIN; ETOPOSIDE; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLIC ACID ANTAGONIST; FOLINIC ACID; IRINOTECAN; MATRIX METALLOPROTEINASE INHIBITOR; METHOTREXATE; OXALIPLATIN; VASCULOTROPIN INHIBITOR;

ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; CARDIA; CLINICAL FEATURE; CLINICAL TRIAL; DRUG CYTOTOXICITY; DRUG TARGETING; FEMALE; GASTRECTOMY; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HUMAN; LOWER ESOPHAGUS SPHINCTER; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENCE RISK; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH FUNDUS; WESTERN HEMISPHERE;

EID: 0037586420     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg726     Document Type: Article

References (44)

1. Gunderson LL, Donohue JH, Burch PA. Stomach. In Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE (eds): Clinical Oncology. New York, NY: Churchill Livingstone 1995; 1209-1241.
2. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics 2002. CA Cancer J Clin 2002; 52: 23-47.
3. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics 2001. CA Cancer J Clin 2001; 51: 15-36.
4. Aoki K. Kurihara M, Hayakawa N et al. (eds). Death Rates for Malignant Neoplasms for Selected Sites by Sex and Five-year Age Group in 33 Countries 1953-57 to 1983-87. Nagoya, Japan: University of Nagoya Coop Press 1992.
5. Coleman MP, Esteve J, Damiecki P et al. (eds). Trends in Cancer Incidence and Mortality, IARC Scientific Publications No. 121. Lyon, France: International Agency for Research on Cancer 1993.
6. Ries LA, Kosary CL, Hankey BE et al. (eds). SEER Cancer Statistics Review 1973-1995. Bethesda. MD: National Cancer Institute 1998.
7. Roder D. The Epidemiology of gastric cancer. Gastric Cancer 2002; In press.
8. South Australian Cancer Registry. Epidemiology of Cancer in South Australia. Incidence, Mortality and Survival, 1977 to 1999. Incidence and Mortality, 1999. Adelaide, Australia: Openbook Publishers 2000.
9. Ilson DH. Adjuvant therapy for noncolorectal cancers. Curr Opin Oncol 2001: 13: 287-290.
10. Bruckner HW, Morris JC, Mansfield P. Neoplasms of the stomach. In Bast RC, Kufe DW, Pollock RE et al. (eds): Cancer Medicine, 5th edition. Hamilton: BC Decker 2000; 1355-1390.
11. American Cancer Society. Facts and Figures 2001. Atlanta, GA: American Cancer Society 2001.
12. Parkin DM. Whelan SL, Ferlay J et al. (eds). Cancer Incidence in Five Continents, Volume VII. IARC Scientific Publications No. 143. Lyon, France: International Agency for Research on Cancer 1997.
13. Nomura A. Stomach cancer. In Schottenfeld D, Fraumeni JF (eds): Cancer Epidemiology and Prevention, 2nd edition. New York, NY: Oxford University Press 1996: 707-724.
14. Parsonnet J, Friedman GD, Vandersteen DP et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-1131.
15. Fendrick AM, Chernew ME, Hirth RA et al. Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer. Arch Intern Med 1999; 159: 142-148.
16. Kono S. Supercourse. Gastric Cancer Epidemiology. Fukuoka, Japan: Kyushu University School of Medicine 2001.
17. Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med 1995; 333: 32-41.
18. Karpeh MS, Kelsu D, Tepper J. Cancer of the stomach. In DeVita VT, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, 6th edition. Philadelphia, Lippincott-William & Wilkins 2001; 1092-1126.
19. Lawrence W. American Cancer Society Textbook of Clinical Oncology, 3rd edition. Atlanta, GA: American Cancer Society 2001. 345-359.
20. Correa P, Chen V. Gastric cancer. In Doll R, Fraumeni JF, Muir CS (eds): Trends in Cancer Incidence and Mortality. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press 1994; 55-76.
21. Blot WJ, Devesa SS, Kneller RW et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. J Am Med Assoc 1991; 265: 1287-1289.
22. Macdonald JS, Hill MC, Roberts IM. Gastric cancer: epidemiology, pathology, detection and staging. In Ahlgren JD, Macdonald JS (eds): Gastrointestinal Oncology. Philadelphia, PA: J.B. Lippincott 1992; 151-158.
23. Hundahl SA, Menck HR, Mansour EG et al. The National Cancer Database report on gastric carcinoma. Cancer 1997; 80: 2333-2341.
24. Spataro V, Genoni M, Maurer C, Muller W. Stomach cancer: 10 years' experience with surgical treatment and possibilities for improving the prognosis. Helv Chir Acta 1993; 59: 589-595.
25. Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987; 11: 418-425.
26. Bunt AMG, Hermans J, Smit VT et al. Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol 1995; 13: 19-25.
27. Bonenkamp JJ, Songun I, Hermans I et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995; 345: 745-748.
28. Bonenkamp JJ, Hermans J, Sasako M et al. Extended lymph node dissection for gastric cancer. N Engl J Med 1999; 340: 908-914.
29. Macintyre IM, Akoh JA. Improving survival in gastric cancer: review of operative mortality in English language publications from 1970. Br J Surg 1991; 78: 771-776.
30. Bottcher K, Siewert JR, Roder JD et al. Risk of surgical therapy of stomach cancer in Germany. Results of the German 1992 Stomach Cancer Study. German Stomach Cancer Study Group ('92). Chirurg 1994; 65: 298-306.
31. Dent DM, Madden MV, Price SK. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg 1988; 75: 110-112.
32. Robertson CS, Chung SC, Woods SD et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1994; 220: 176-182.
33. Cuschieri A, Fayers P, Fielding J et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet 1996; 347: 995-999.
34. Macdonald JS, Smalley SR, Benedetti J et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345: 725-730.
35. Glimelius B, Ekstrom K, Hoffman K et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol 1997; 8: 163-168.
36. Hill ME, Cunningham D. Medical management of advanced gastric cancer. Cancer Treat Rev 1998; 248: 113-118.
37. Waters JS, Norman D, Cunningham D et al. Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial. Br J Cancer 1999; 80: 269-272.
38. Cullinan SA, Moertel CG, Wieand HS et al. Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group. J Clin Oncol 1994; 12: 412-416.
39. Panzini I, Gianni L, Fattori PP et al. Adjuvant chemotherapy in gastric cancer: A meta-analysis of randomized trials and a comparison with previous meta-analyses. Tumori 2002; 88: 21-27.
40. Janunger KG, Hafstrom L, Nygren P et al. A systematic overview of chemotherapy effects in gastric cancer. Acta Oncol 2001; 40: 309-326.
41. Gianni L, Panzini I, Tassinari D et al. Meta-analyses of randomized trials of adjuvant chemotherapy in gastric cancer. Ann Oncol 2001; 12: 1179-1180.
42. Hermans J, Bonenkamp JJ, Boon MC et at. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 1993; 11: 1441-1447.
43. Earle CC, Maroun JA. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. Eur J Cancer 1999; 35: 1059-1064.
44. Mari E, Floriani I. Tinazzi A et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann Oncol 2000; 11: 837-843.